Search
Nektar Therapeutics
NKTRAdd to Watchlist
60.980USD
+0.060+0.10%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM
Nektar Therapeutics's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Nektar Therapeutics is 6.87, ranking 283 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.70, which is -99.79% below the recent high of -0.02 and -34.29% above the recent low of -10.34.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
